Funding:
Clinical challenges in the SOCMA study were funded through grant funds
awarded by Jon Moulton Charity Trust, UK Medical Research Council (ref
MR/S036954/1), Sociedad Española de Alergología e Inmunología Clínica
(SEAIC), Sociedad Española de Inmunología Clínica, Alergología y Asma
Pediátrica (SEICAP) and Instituto de Salud Carlos III and FEDER funds
for the ARADyAL research network (RD16/006/0026). RB is supported by a
Río Hortega Research Contract through the Instituto de Salud Carlos III
and the European Social Fund (ref CM20/00253). MVO was supported by a
Marie Skłodowska-Curie actions - Research Fellowship funded by the
Commission of the European Communities (reference: 656878). PJT is
supported through the NIHR Biomedical Research Centre based at Imperial
College Healthcare NHS Trust and Imperial College London. The views
expressed are those of the author(s) and not necessarily those of the
NHS, NIHR, or the Department of Health.
The funders of the study had no role in study design, data collection,
data analysis, data interpretation or writing of the report. The
corresponding author had full access to all the data in the study and
had final responsibility for the decision to submit for publication.